Introduction: This study aimed to compare estimates of stroke volume (SV) from different anatomic sites and to generate reference intervals for indices such as shunt volume (ShuntVol) or regurgitant volume (RegVol) in a large sample of healthy dogs.
Animals, Materials And Methods: Ninety healthy dogs underwent an echocardiogram, where SV was assessed at the level of the pulmonary valve (SV), aortic valve (SV), mitral valve (SV), and left ventricle using the difference in end-diastolic volume and end-systolic volume from a right parasternal long-axis four-chamber view (SV) and left apical four-chamber view (SV). Eight dogs underwent repeated echocardiograms by the same operator on three different days and by three different operators on the same day. Bland-Altman plots and 95% reference intervals were generated. Reproducibility was described using coefficients of variation and reproducibility coefficients.
Results: Mean differences (95% limits of agreement) for ShuntVol (SV-SV), RegVol (SV-SV), RegVol (SV-SV), and RegVol (SV-SV) were as follows: -0.14 (-0.72, 0.44), -0.05 (-0.59, 0.48), -0.16 (-0.71, 0.39), and 0.12 (-0.76, 1.00) mL/kg, respectively. All but RegVol showed significant (P<0.01) fixed bias. Reference intervals for ShuntVol, RegVol, RegVol, and RegVol were as follows: -0.85-0.64, -0.65-0.58, -0.77-0.52, and -0.91-1.06 mL/kg, respectively. Intra-operator and interoperator coefficients of variation were lowest for SV and highest for SV and SV.
Conclusions: Echocardiographic estimates of SV are not interchangeable and can exhibit wide limits of agreement. Reference intervals help provide a frame of reference to assess disease severity in dogs with a shunting lesion (ShuntVol) and mitral regurgitation (RegVol).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvc.2024.10.008 | DOI Listing |
Acta Cardiol Sin
January 2025
School of Medicine, National Yang Ming Chiao Tung University.
Background: The obesity paradox refers to lower mortality rates among overweight or obese individuals within certain populations. However, whether this paradox is applicable to patients undergoing percutaneous coronary intervention (PCI) remains unclear.
Methods: A total of 5,427 patients with coronary artery disease (CAD) who underwent successful PCI between 2005 and 2015 were enrolled.
Neurocrit Care
January 2025
Center for Data Science, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.
Background: Neurovascular coupling (NVC) refers to the process of aligning cerebral blood flow with neuronal metabolic demand. This study explores the potential of contralateral NVC-linking neural electrical activity on the stroke side with cerebral blood flow velocity (CBFV) on the contralesional side-as a marker of physiological function of the brain. Our aim was to examine the association between contralateral NVC and neurological outcomes in patients with ischemic stroke following endovascular thrombectomy.
View Article and Find Full Text PDFCochrane Database Syst Rev
January 2025
Faculty of Physical Education and Physiotherapy, Rehabilitation Research Group, Vrije Universiteit Brussel, Brussels, Belgium.
Background: Multiple sclerosis (MS) is the most common neurological disease in young adults. Virtual reality (VR) offers a promising rehabilitation tool by providing controllable, personalised environments for safe, adaptable and engaging training. Virtual reality can be tailored to patients' motor and cognitive skills, enhancing motivation through exciting scenarios and feedback.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Coaching Education, Akdeniz University, Antalya, Türkiye.
Relative age effects (RAEs) refer to all consequences of chronological age-based systems. The purpose of this study was to investigate the prevalence of RAEs among Turkish racket sports players. As a nationwide analysis, the present study extends beyond the typical investigations of elite-level popular sports by examining RAEs in racket sports players from the lowest grassroots level to the top and from children to veteran athletes.
View Article and Find Full Text PDFJ Neurol
January 2025
John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle-upon-Tyne, UK.
PROPEL (ATB200-03; NCT03729362) compared the efficacy and safety of cipaglucosidase alfa plus miglustat (cipa + mig), a two-component therapy for late-onset Pompe disease (LOPD), versus alglucosidase alfa plus placebo (alg + pbo). The primary endpoint was change in 6-min walk distance (6MWD) from baseline to week 52. During PROPEL, COVID-19 interrupted some planned study visits and assessment windows, leading to delayed visits, make-up assessments for patients who missed ≥ 3 successive infusions before planned assessments at weeks 38 and 52, and some advanced visits (end-of-study/early-termination visits).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!